Finally, the fact that some patients survived for more than half a year with no surgical or oncological treatment suggests that the process of selecting patients for BSC vs aggressive treatments needs refinement.doi:10.1093/neuonc/noab195.016Riley James...
Multiscale analysis of a regenerative therapy for treatment of volumetric muscle loss injury Carlos A. Aguilar Sarah M. Greising Benjamin T. Corona ArticleOpen Access20 Feb 2018 Cell Death Discovery Two-in-one: UV radiation simultaneously induces apoptosis and NETosis Dhia Azzouz Meraj A. ...
Oncolytic viruses have also emerged as an additional therapeutic agent for cancer treatment. These viruses are designed to target and kill tumor cells while leaving the normal cells unharmed. As part of this process, oncolytic virus infection stimulates anti-cancer immune responses that augment the ...
We performed a treatment-based analysis of data from the pivotal phase III trial of the NovoTTF-100A System versus best physician's choice (BPC) chemotherapy in patients with recurrent glioblastoma multiforme (GBM), with particular focus on efficacy in patients using NovoTTF Therapy as intended. ...
Introduction The treatment of cancer remains considered as one of the most challenging health issue. Despite recent, intensive, and rapid advances in new technologies, drugs, and therapies against cancer during the last decades, the glioblastoma multiforme (GBM) is still the most prevalent (14.5% ...